Results 121 to 130 of about 27,057 (223)

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations [PDF]

, 2016
Barbui, T, Barosi, G, Birgegård, G, Cervantes, F, Griesshammer, M, Harrison, C., Hehlmann, R, Kiladjian, J-J, Kröger, N, Marchetti, M, McMullin, M F, Passamonti, F, Vannucchi, A   +12 more
core   +1 more source

Prognostic value of anemia plus thrombocytopenia in primary myelofibrosis. [PDF]

Leukemia
Barosi G, De Silvestri A, Gale RP, Rosti V.   +3 more
europepmc   +1 more source

Recent advances in therapies for primary myelofibrosis. [PDF]

Fac Rev, 2023
Vainchenker W, Yahmi N, Havelange V, Marty C, Plo I, Constantinescu SN.   +5 more
europepmc   +1 more source

Pulmonary arterial hypertension exacerbated by ruxolitinib [PDF]

, 2015
Harrison, C, Howard, L, Low, AT, Tulloh, RMR   +3 more
core   +2 more sources

Cutaneous Extramedullary Hematopoiesis in Primary Myelofibrosis: A Case Report With Rapidly Fatal Outcome. [PDF]

Cureus
El Bouhmadi A, Baghad B, Rachadi H, Benhayoun FZ, Chiheb S.   +4 more
europepmc   +1 more source

Complete resolution of primary myelofibrosis in an infant with steroids and hydroxyurea. [PDF]

BMJ Case Rep, 2023
Khera S, Misra P, Singh K, Tripathi P.
europepmc   +1 more source

Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome. [PDF]

Blood Cancer J
Bashir YA, Abdelrheem AA, Abdelmagid M, Reichard KK, He R, Zepeda Mendoza CJ, Pardanani A, Gangat N, Tefferi A.   +8 more
europepmc   +1 more source

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [PDF]

, 2017
DiPersio, John F, et al,
core   +1 more source

Reticulosarcomatosis in primary myelofibrosis [PDF]

Cancer, 1968
openaire   +2 more sources

Spectrum of Kidney Biopsy Findings in a Patient With Primary Myelofibrosis. [PDF]

Kidney Int Rep
Dzedzik S, Alobeid B, Reddy S, D'Agati VD.   +3 more
europepmc   +1 more source